Recognizing the significance of fluid biomarkers and their role in disease progression and therapy response is crucial for the success of clinical trials. Identifying and selecting biomarkers during the pre-clinical stages can lead to a 164% higher success rate in Phase II-III clinical trials.
Uncover a Multitude of Insights from a Single Sample. Experience DNA, RNA, and Protein Analysis for faster, more sensitive results with proven PCR technology, multiplexed for more comprehensive answers.
One instrument, One workflow, comprehensive answers
Transforming Timelines, Efficiency and Savings with the Codetta Solution
Transform time-saving: Cut analysis time from 2 Days to Just 2 Hours, allowing for faster decision-making and more efficient processes.
Combining the precision of digital PCR with the dynamic range of qPCR enables multiplex biomarker measurement at fM levels.
Replace separate instruments with one all-in-one solution. A single, multifunctional instrument reduces the need for multiple tools, streamlining workflows, reducing costs, and saving space.
Adopt a fully-integrated workflow with a simple setup and two- to three-hour assay run time.
Jacques Corriveau
CEO, Codetta BioTM
Learn how you can experience the Codetta Bio Platform by joining the Technology Access Program.